Delivery Order SPE2DB24D2010-SPE2DB24FZVV3

Award Date 7/8/24
Potential Completion Date 7/29/24
Potential Value $8.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division involves the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a pharmaceutical product, to the Defense Logistics Agency (DLA) over a 2-year period from June 2024 to July 2024. The contract has a ceiling value of $8,379.09 and is structured as a firm-fixed price delivery order. Amerisourcebergen, a large pharmaceutical distribution company, is the prime contractor for this award, which is part of a larger...
This federal contract award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of the drug BENLYSTA 200 MG/ML AUTOINJECTOR. The ceiling value of this Firm Fixed Price Delivery Order contract is $5,586.06, with a completion date of May 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $12,595.00 and an ultimate completion date of June 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication. The contract, valued at $8,379.09, was awarded by the Defense Logistics Agency (DLA) and has a completion date of May 30, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The $3,082.67 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 28, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the pharmaceutical product Benlysta 200 mg/ml autoinjector, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,082.67 and is a delivery order with a firm fixed price, awarded by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,082.67 for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through February 3, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, with a ceiling value of $6,165.34. The contract has a period of performance through April 30, 2025 and is a firm fixed-price delivery order. This award is not associated with a set-aside designation....
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product. The contract has a Ceiling Value of $2,793.03 and a completion date of May 8, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. This contract is part of a larger Indefinite Delivery Contract...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the medical product BENLYSTA 200 MG/ML AUTOINJECTML. The contract has a ceiling value of $24,661.36 and runs through February 14, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZVV3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,379.09 and runs through July 29, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 10/7/24, 10:56 AM